JS Link, Inc. (KOSDAQ:127120)
South Korea
· Delayed Price · Currency is KRW 42,300
-1,400 (-3.20%)
At close: Apr 28, 2026
JS Link Revenue
In the year 2025, JS Link had annual revenue of 19.32B KRW with 21.43% growth. JS Link had revenue of 8.88B in the quarter ending December 31, 2025, with 55.69% growth.
Revenue
19.32B
Revenue Growth
+21.43%
P/S Ratio
75.55
Revenue / Employee
229.96M
Employees
84
Market Cap
1,459.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 19.32B | 3.41B | 21.43% |
| Dec 31, 2024 | 15.91B | -6.04B | -27.52% |
| Dec 31, 2023 | 21.95B | 4.97B | 29.26% |
| Dec 31, 2022 | 16.98B | -6.01B | -26.14% |
| Dec 31, 2021 | 22.99B | 7.71B | 50.41% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Qurient | 6.98B |
| AprilBio | 2.17B |
| ROKIT Healthcare | 26.25B |
| Inventage Lab | 2.94B |
| Aimed Bio | 47.28B |
| IntoCell | 2.30B |
| HansBiomed | 100.17B |